News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Molineaux Susan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 6,191 shares
@ $0 |
|
| 06/30/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 4,088 shares
@ $0 |
|
| 06/12/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on Repare Therapeutics Inc.|
Txns:
| Granted 76,200 options to buy
@ $11.66, valued at
$888.5k
|
|
| 06/12/2023 |
3
| Molineaux Susan (Director) has filed a Form 3 on Repare Therapeutics Inc. |
| 06/02/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 125,000 options to buy
@ $3.27, valued at
$408.8k
|
|
| 05/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 6,048 shares
@ $0 |
|
| 02/07/2023 |
4
| Molineaux Susan (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $1.69, valued at
$23.9k
|
|
| 01/25/2023 |
4
| Molineaux Susan (PRESIDENT & CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 526 shares
@ $0.4461, valued at
$234.6 |
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Molineaux Susan (Director) has filed a Form 4 on Cyteir Therapeutics, Inc.|
Txns:
| Granted 14,150 options to buy
@ $5.96, valued at
$84.3k
|
|
| 01/27/2022 |
4
| Molineaux Susan (PRESIDENT & CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 597,475 options to buy
@ $0.44, valued at
$262.9k
|
|
| 11/10/2021 |
4
| Molineaux Susan (PRESIDENT & CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Bought 100,000 shares
@ $0.8467, valued at
$84.7k
|
|
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Molineaux Susan (PRESIDENT & CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 85,000 shares
@ $0
Granted 375,000 options to buy
@ $2.98, valued at
$1.1M
|
|
| 06/09/2020 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 83,000 options to buy
@ $1.54, valued at
$127.8k
|
|
| 04/30/2020 |
4
| Molineaux Susan (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 6,635 shares
@ $0
Granted 6,000 options to buy
@ $30.14, valued at
$180.8k
|
|
| 01/22/2020 |
4
| Molineaux Susan (PRESIDENT AND CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 400,000 options to buy
@ $7.41, valued at
$3M
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 70,000 options to buy
@ $1.38, valued at
$96.6k
|
|
| 05/02/2019 |
4
| Molineaux Susan (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 8,385 shares
@ $0
Granted 6,000 options to buy
@ $23.85, valued at
$143.1k
|
|
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2019 |
4
| Molineaux Susan (PRESIDENT AND CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 390,000 options to buy
@ $4.64, valued at
$1.8M
|
|
| 01/02/2019 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 13,125 shares
@ $0 |
|
| 11/16/2018 |
4
| Molineaux Susan (PRESIDENT AND CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Gifted 6,476 shares
@ $0 |
|
| 09/28/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2018 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 3,827 shares
@ $0 |
|
| 05/17/2018 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 70,000 options to buy
@ $3.43, valued at
$240.1k
|
|
| 05/03/2018 |
4
| Molineaux Susan (Director) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 8,186 shares
@ $0
Granted 6,000 options to buy
@ $24.43, valued at
$146.6k
|
|
| 03/30/2018 |
4
| Molineaux Susan (Director) has filed a Form 4 on GERON CORP|
Txns:
| Granted 3,088 shares
@ $0 |
|
| 03/06/2018 |
4
| Molineaux Susan (PRESIDENT AND CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Exercised 26,992 options to buy
@ $2.64, valued at
$71.3k
Exercised 6,798 options to buy
@ $2.64, valued at
$17.9k
|
|
| 01/16/2018 |
4
| Molineaux Susan (PRESIDENT AND CEO) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 200,000 options to buy
@ $8.6, valued at
$1.7M
|
|
|
|
|